Weiss Multi Strategy Advisers LLC Amgen Inc Transaction History

Weiss Multi Strategy Advisers LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.11 Million - $5.1 Million	18,781 New	18,781 $5.05 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $3.16 Million - $3.86 Million	-14,016 Reduced 53.49%	12,186 $2.95 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $6 Million - $7.63 Million	26,202 New	26,202 $6.88 Million

3,084

401M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.